US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Everus Construction Group, Inc.

88.09

-13.1200-12.96%

Post-market: 88.090.00000.00%17:56 EST

Volume:1.71M

Turnover:153.37M

Market Cap:4.49B

PE:24.89

High:101.12

Open:101.12

Low:84.58

Close:101.21

52wk High:103.08

52wk Low:31.38

Shares:51.01M

Float Shares:50.85M

Volume Ratio:3.36

T/O Rate:3.37%

Dividend:- -

Dividend Rate:- -

EPS(TTM):3.54

EPS(LYR):2.81

ROE:35.26%

ROA:10.41%

PB:7.84

PE(LYR):31.31

Loading ...

Overview Company News Filings

Milestone Receives FDA Approval of CARDAMYST™ (etripamil) as First and Only Self-Administered Nasal Spray for Adults with Paroxysmal Supraventricular Tachycardia (PSVT)

Revuforj® (revumenib) Named Best New Drug at the Scrip Awards 2025

OMRON Healthcare Unveils Global ECG Strategy

Why Is Micro Cap HeartBeam Stock Surging On Wednesday?

Benzinga_recent_news

Director Helena Mercedes Hernandez Acquires Common Shares of Everus Construction Group Inc

Syndax Highlights Leadership in Menin Inhibition at ASH 2025 with Multiple Revuforj® (revumenib) Presentations Spanning the Acute Leukemia Treatment Continuum

iRhythm Technologies (IRTC) Valuation After New Global Zio ECG Data From Major Cardiac Conference

Simply Wall St.

Zio ECG Study Shows Cross-Population Efficacy and Might Change The Case For Investing In iRhythm Technologies (IRTC)

Simply Wall St.

Transtek Medical Electronics' Unit Renews Registration Certificate for ECG Information Network Software

MT Newswires Live

NeuralCloud Expands AI ECG Technology into Equine Health with Equimetrics Partnership

Everus Construction Group (NYSE:ECG): Assessing Valuation After Recent Share Price Volatility

Simply Wall St.

Everus Construction Group Names Kenny Whipple Vice President of Business Development

Press Release: JD.com Announces Third Quarter 2025 Results

HeartBeam (NASDAQ: BEAT) Recognized as a Top Global Innovator in Portable ECG Technology

AI/ML Innovations Secures U.S. Patent for ECG Signal-Processing Technology

CardioComm Secures Funding for ECG Platform Expansion

Everus Construction Group Inc. details growth strategy and national platform in investor presentation

MDU Resources Group Inc. highlights focus on regulated energy delivery and growth strategy in new investor presentation

Everus Construction Group Inc : Oppenheimer Raises Target Price to $105 From $90

THOMSON REUTERS

Stifel Nicolaus Keeps Their Buy Rating on Everus Construction Group, Inc. (ECG)

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/ECG/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ECG","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ECG\",,,,,undefined,":{"symbol":"ECG","market":"US","secType":"STK","nameCN":"Everus Construction Group, Inc.","latestPrice":88.09,"timestamp":1765573200000,"preClose":101.21,"halted":0,"volume":1713938,"hourTrading":{"tag":"盘后","latestPrice":88.09,"preClose":88.09,"latestTime":"17:56 EST","volume":38837,"amount":3421170.99,"timestamp":1765580176166},"delay":0,"floatShares":50847531,"shares":51006575,"eps":3.53914,"marketStatus":"Market Closed","change":-13.12,"latestTime":"12-12 16:00:00 EST","open":101.12,"high":101.12,"low":84.58,"amount":153371450.56054,"amplitude":0.163423,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":3.53914,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1765789200000},"marketStatusCode":7,"adr":0,"exchange":"NYSE","adjPreClose":101.21,"preHourTrading":{"tag":"盘前","latestPrice":101,"preClose":101.21,"latestTime":"08:00 EST","volume":3228,"amount":327109.60596,"timestamp":1765544400256},"postHourTrading":{"tag":"盘后","latestPrice":88.09,"preClose":88.09,"latestTime":"17:56 EST","volume":38837,"amount":3421170.99,"timestamp":1765580176166},"volumeRatio":3.362413837612781,"impliedVol":0.5259,"impliedVolPercentile":0.4144},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ECG\",,,,,undefined,":{"symbol":"ECG","floatShares":50847531,"roa":"10.41%","roe":"35.26%","lyrEps":2.813666,"volumeRatio":3.362413837612781,"shares":51006575,"dividePrice":0,"high":101.12,"amplitude":0.163423,"preClose":101.21,"low":84.58,"week52Low":31.38,"pbRate":"7.84","psRate":"1.29","week52High":103.08,"institutionHeld":0,"latestPrice":88.09,"eps":3.53914,"divideRate":0,"volume":1713938,"delay":0,"ttmEps":3.53914,"open":101.12,"prevYearClose":65.75,"prevWeekClose":91.75,"prevMonthClose":91.96,"prevQuarterClose":85.75,"fiveDayClose":91.75,"twentyDayClose":91.58,"sixtyDayClose":81.89},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ECG\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-04","symbol":"ECG","fiscalQuarterEnding":"2025/09","expectedEps":0.62,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1762232400000,"reportTimeType":"post","actualEps":1.11},{"market":"US","date":"2025-08-12","symbol":"ECG","fiscalQuarterEnding":"2025/06","expectedEps":0.61,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1754971200000,"reportTimeType":"post","actualEps":1.03},{"market":"US","date":"2025-05-13","symbol":"ECG","fiscalQuarterEnding":"2025/03","expectedEps":0.43,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1747108800000,"reportTimeType":"post","actualEps":0.72},{"market":"US","date":"2025-02-11","symbol":"ECG","fiscalQuarterEnding":"2024/12","expectedEps":0.73,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1739250000000,"reportTimeType":"post","actualEps":0.67}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ECG\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ECG\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5,"buy":0,"hold":0.5,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0,"analysts":4,"updateTime":1733374800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ECG\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ECG","date":"2025-12-11","current":24.890228,"percent":0.892989,"low":11.94786,"twenty":16.658219,"median":23.613932,"eighty":25.8411,"high":28.892955,"avg":22.277119,"sd":4.647106,"marketCap":4909382843},"quantilePoints":[{"date":"2024-11-15","current":19.884731,"twenty":20.580031,"median":21.388177,"eighty":22.118522,"marketCap":2892154627},{"date":"2024-11-22","current":22.527151,"twenty":20.580031,"median":21.221711,"eighty":22.118522,"marketCap":3276483952},{"date":"2024-11-29","current":22.309869,"twenty":20.774883,"median":21.784189,"eighty":22.44935,"marketCap":3244881275},{"date":"2024-12-06","current":23.914946,"twenty":20.948708,"median":22.309869,"eighty":22.694667,"marketCap":3478333306},{"date":"2024-12-13","current":24.1112,"twenty":21.255005,"median":22.386969,"eighty":23.504916,"marketCap":3506877659},{"date":"2024-12-20","current":22.639296,"twenty":21.463875,"median":22.621773,"eighty":23.900227,"marketCap":3292795011},{"date":"2024-12-27","current":25.796882,"twenty":21.726014,"median":22.804009,"eighty":24.031297,"marketCap":3752053262},{"date":"2025-01-03","current":24.279418,"twenty":22.045628,"median":23.042317,"eighty":24.098584,"marketCap":3531344247},{"date":"2025-01-10","current":23.36123,"twenty":22.054038,"median":23.36123,"eighty":24.167273,"marketCap":3397797452},{"date":"2025-01-17","current":23.231562,"twenty":22.309869,"median":23.296396,"eighty":24.223346,"marketCap":3378937791},{"date":"2025-01-24","current":26.403166,"twenty":22.309869,"median":23.448843,"eighty":24.416796,"marketCap":3840234925},{"date":"2025-01-31","current":24.703467,"twenty":22.363139,"median":23.511925,"eighty":24.431515,"marketCap":3593020438},{"date":"2025-02-07","current":24.784071,"twenty":22.393278,"median":23.631079,"eighty":24.431515,"marketCap":3604744012},{"date":"2025-02-14","current":17.609659,"twenty":22.363139,"median":23.694161,"eighty":24.484083,"marketCap":2525594974},{"date":"2025-02-21","current":16.543269,"twenty":22.049833,"median":23.511925,"eighty":24.443431,"marketCap":2372652202},{"date":"2025-02-28","current":14.893919,"twenty":20.948708,"median":23.398027,"eighty":24.417497,"marketCap":2136100715},{"date":"2025-03-07","current":14.060071,"twenty":19.828659,"median":23.326185,"eighty":24.358924,"marketCap":2016509475},{"date":"2025-03-14","current":13.437787,"twenty":16.836882,"median":23.135188,"eighty":24.308591,"marketCap":1927260826},{"date":"2025-03-21","current":14.294761,"twenty":15.304834,"median":22.94419,"eighty":24.287829,"marketCap":2050168965},{"date":"2025-03-28","current":12.43502,"twenty":14.540119,"median":22.651562,"eighty":24.245775,"marketCap":1783443003},{"date":"2025-04-04","current":12.555921,"twenty":14.128344,"median":22.527151,"eighty":24.214935,"marketCap":1800782740},{"date":"2025-04-11","current":13.501793,"twenty":13.910012,"median":22.343162,"eighty":24.184095,"marketCap":1936440687},{"date":"2025-04-17","current":13.572911,"twenty":13.722422,"median":22.181953,"eighty":24.146246,"marketCap":1946640532},{"date":"2025-04-25","current":14.568566,"twenty":13.695946,"median":21.51434,"eighty":24.113303,"marketCap":2089438371},{"date":"2025-05-02","current":15.233522,"twenty":13.71017,"median":20.922073,"eighty":24.085968,"marketCap":2184806927},{"date":"2025-05-09","current":17.164381,"twenty":13.722422,"median":19.902399,"eighty":24.031297,"marketCap":2461732735},{"date":"2025-05-16","current":20.563833,"twenty":13.745616,"median":19.893565,"eighty":23.999055,"marketCap":3123214340},{"date":"2025-05-23","current":21.992869,"twenty":13.78911,"median":20.563833,"eighty":23.959104,"marketCap":2926865953},{"date":"2025-05-30","current":22.176813,"twenty":13.823958,"median":20.788901,"eighty":23.91004,"marketCap":2951345752},{"date":"2025-06-06","current":23.146354,"twenty":13.877297,"median":21.451259,"eighty":23.877799,"marketCap":3080374692},{"date":"2025-06-13","current":23.161683,"twenty":13.948415,"median":21.770602,"eighty":23.816119,"marketCap":3082414675},{"date":"2025-06-20","current":22.912591,"twenty":13.971173,"median":22.043525,"eighty":23.771261,"marketCap":3049264947},{"date":"2025-06-27","current":23.740342,"twenty":14.060071,"median":22.121246,"eighty":23.740342,"marketCap":3159424042},{"date":"2025-07-03","current":24.970471,"twenty":14.07145,"median":22.251005,"eighty":23.895321,"marketCap":3323132697},{"date":"2025-07-11","current":25.805886,"twenty":14.153947,"median":22.376456,"eighty":24.052477,"marketCap":3434311784},{"date":"2025-07-18","current":26.518671,"twenty":14.202307,"median":22.526346,"eighty":24.175684,"marketCap":3529171005},{"date":"2025-07-25","current":26.442027,"twenty":14.212264,"median":22.621773,"eighty":24.30109,"marketCap":3518971089},{"date":"2025-08-01","current":28.457753,"twenty":14.278404,"median":22.671329,"eighty":24.416796,"marketCap":3787228885},{"date":"2025-08-08","current":27.411568,"twenty":14.30614,"median":22.782297,"eighty":24.537352,"marketCap":3648000028},{"date":"2025-08-15","current":23.175295,"twenty":14.422774,"median":22.810398,"eighty":24.635911,"marketCap":3841305163},{"date":"2025-08-22","current":23.323006,"twenty":14.493892,"median":22.904927,"eighty":24.537352,"marketCap":3865788319},{"date":"2025-08-29","current":24.713955,"twenty":14.521629,"median":22.920255,"eighty":24.537352,"marketCap":4096338038},{"date":"2025-09-05","current":23.815378,"twenty":14.551498,"median":22.978193,"eighty":24.507914,"marketCap":3947398839},{"date":"2025-09-12","current":24.372372,"twenty":14.649641,"median":23.042317,"eighty":24.488989,"marketCap":4039720740},{"date":"2025-09-19","current":25.200171,"twenty":14.753844,"median":23.089828,"eighty":24.488989,"marketCap":4176928426},{"date":"2025-09-26","current":24.396991,"twenty":14.851263,"median":23.146354,"eighty":24.588002,"marketCap":4043801266},{"date":"2025-10-03","current":25.117084,"twenty":14.97923,"median":23.180649,"eighty":24.722376,"marketCap":4163156651},{"date":"2025-10-10","current":27.003481,"twenty":15.154555,"median":23.193759,"eighty":24.845751,"marketCap":4475826956},{"date":"2025-10-17","current":27.852821,"twenty":15.383802,"median":23.275964,"eighty":25.02914,"marketCap":4616605103},{"date":"2025-10-24","current":26.926548,"twenty":15.791108,"median":23.323006,"eighty":25.217404,"marketCap":4463075312},{"date":"2025-10-31","current":27.600481,"twenty":16.024903,"median":23.341955,"eighty":25.414653,"marketCap":4574779711},{"date":"2025-11-07","current":27.713121,"twenty":16.093341,"median":23.36123,"eighty":25.523906,"marketCap":5014966454},{"date":"2025-11-14","current":25.813341,"twenty":16.136723,"median":23.428153,"eighty":25.800484,"marketCap":4671182138},{"date":"2025-11-21","current":22.66771,"twenty":16.383495,"median":23.439945,"eighty":25.708429,"marketCap":4101948761},{"date":"2025-11-28","current":25.92045,"twenty":16.548957,"median":23.449096,"eighty":25.737913,"marketCap":4690564637},{"date":"2025-12-05","current":26.630754,"twenty":16.561288,"median":23.487393,"eighty":25.810359,"marketCap":4819101206},{"date":"2025-12-11","current":27.129658,"twenty":16.658219,"median":23.613932,"eighty":25.8411,"marketCap":4909382843}],"updateTime":1765588938149},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ECG\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2591263835","title":"Milestone Receives FDA Approval of CARDAMYST™ (etripamil) as First and Only Self-Administered Nasal Spray for Adults with Paroxysmal Supraventricular Tachycardia (PSVT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2591263835","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591263835?lang=en_us&edition=fundamental","pubTime":"2025-12-13 09:00","pubTimestamp":1765587600,"startTime":"0","endTime":"0","summary":"First FDA approved treatment in 30+ years for more than 2 million Americans with PSVTNovel nasal spray designed to rapidly resolve episodes of PSVT and restore sinus rhythmFDA approval in PSVT enables","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/12/13/3204944/0/en/Milestone-Receives-FDA-Approval-of-CARDAMYST-etripamil-as-First-and-Only-Self-Administered-Nasal-Spray-for-Adults-with-Paroxysmal-Supraventricular-Tachycardia-PSVT.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4096","SVT","BK4129","ECG"],"gpt_icon":0},{"id":"2590505296","title":"Revuforj® (revumenib) Named Best New Drug at the Scrip Awards 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2590505296","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590505296?lang=en_us&edition=fundamental","pubTime":"2025-12-12 20:00","pubTimestamp":1765540800,"startTime":"0","endTime":"0","summary":"NEW YORK, Dec.  12, 2025  (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced that Revuforj (","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/12/12/3204567/0/en/Revuforj-revumenib-Named-Best-New-Drug-at-the-Scrip-Awards-2025.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1699723380.USD","BK4107","BK4533","LU1571399168.USD","ECG","BK4585","LU2355687059.USD","ALL","BK4588","BK4129","LU0985320562.USD"],"gpt_icon":0},{"id":"2590567719","title":"OMRON Healthcare Unveils Global ECG Strategy","url":"https://stock-news.laohu8.com/highlight/detail?id=2590567719","media":"prnewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590567719?lang=en_us&edition=fundamental","pubTime":"2025-12-11 15:00","pubTimestamp":1765436400,"startTime":"0","endTime":"0","summary":"New services and strategic partnerships advance Going for ZERO visionTOKYO, Dec. 11, 2025 /PRNewswire/ -- OMRON Healthcare Co., Ltd. announced new initiatives to accelerate its global electrocardiogram  business strategy, positioning it as a key driver of the company's cardiovascular vision, Going for ZERO. The strategy, first presented at a press conference held in Tokyo on November 12, 2025, includes additional investment in Indian AI healthtech company Tricog Health India Private Limited and the planned transfer of the Heartnote ECG service business from JSR Corporation.\"Confronting the heart failure 'pandemic' and the shortage of cardiovascular specialists requires new approaches,\" said Ayumu Okada, President and CEO, OMRON Healthcare Co., Ltd. \"By combining innovative technology with strategic partnerships, we aim to take our cardiovascular business to the next stage and help prevent serious cardiac events before they occur.\"","market":"us","thumbnail":"https://mma.prnewswire.com/media/2843331/Speakers_OMRON_HEALTHCARE_press_conference_November_12_2025.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/2843331/Speakers_OMRON_HEALTHCARE_press_conference_November_12_2025.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/omron-healthcare-unveils-global-ecg-strategy-302638788.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XLV","XBI","CFA.SI","BK4588","BK4137","HCSG","LABU","BK4129","ECG.AU","LU0029874061.USD","ECG","LU0128526141.USD","BK7064","BK4581","BK4585"],"gpt_icon":0},{"id":"2590397875","title":"Why Is Micro Cap HeartBeam Stock Surging On Wednesday?","url":"https://stock-news.laohu8.com/highlight/detail?id=2590397875","media":"Benzinga_recent_news","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590397875?lang=en_us&edition=fundamental","pubTime":"2025-12-11 00:27","pubTimestamp":1765384020,"startTime":"0","endTime":"0","summary":"HeartBeam shares rise after FDA clears its 12-lead ECG software, boosting plans for a 2026 launch and expanded cardiac detection technology.","market":"hk","thumbnail":"https://cdn.benzinga.com/files/images/story/2025/12/10/Chest-Pain-Illness-Causing-Heart-Attack-.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2025/12/10/Chest-Pain-Illness-Causing-Heart-Attack-.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/news/fda/25/12/49310554/why-is-micro-cap-heartbeam-stock-surging-on-wednesday","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/fda/25/12/49310554/why-is-micro-cap-heartbeam-stock-surging-on-wednesday","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["BK4082","ECG","BK4129","BEAT"],"gpt_icon":0},{"id":"2590610369","title":"Director Helena Mercedes Hernandez Acquires Common Shares of Everus Construction Group Inc","url":"https://stock-news.laohu8.com/highlight/detail?id=2590610369","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590610369?lang=en_us&edition=fundamental","pubTime":"2025-12-09 06:11","pubTimestamp":1765231881,"startTime":"0","endTime":"0","summary":"Helena Mercedes Hernandez, Director of Everus Construction Group Inc., has reported the acquisition of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Everus Construction Group Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 08, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251208:nNDL8QT9Jb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Director Helena Mercedes Hernandez Acquires Common Shares of Everus Construction Group Inc","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4129","ECG"],"gpt_icon":0},{"id":"2589533799","title":"Syndax Highlights Leadership in Menin Inhibition at ASH 2025 with Multiple Revuforj® (revumenib) Presentations Spanning the Acute Leukemia Treatment Continuum","url":"https://stock-news.laohu8.com/highlight/detail?id=2589533799","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589533799?lang=en_us&edition=fundamental","pubTime":"2025-12-08 19:50","pubTimestamp":1765194600,"startTime":"0","endTime":"0","summary":"– First real-world evidence for a menin inhibitor shows 77% ORR (10/13), 31% (4/13) CR/CRh, 75% (9/12) MRD negativity, and favorable tolerability among primarily R/R NPM1m, KMT2Ar, and NUP98r acute le","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/12/08/3201378/0/en/Syndax-Highlights-Leadership-in-Menin-Inhibition-at-ASH-2025-with-Multiple-Revuforj-revumenib-Presentations-Spanning-the-Acute-Leukemia-Treatment-Continuum.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0985320562.USD","LU1699723380.USD","LU2355687059.USD","ORR","BK4533","OS","LU1571399168.USD","BK4107","ASH","LU2463526074.USD","CR","BK4585","ALL","BK4109","BK4097","BK4161","BK4129","BK4588","ECG","HSCT"],"gpt_icon":0},{"id":"2588013769","title":"iRhythm Technologies (IRTC) Valuation After New Global Zio ECG Data From Major Cardiac Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2588013769","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588013769?lang=en_us&edition=fundamental","pubTime":"2025-12-03 15:19","pubTimestamp":1764746347,"startTime":"0","endTime":"0","summary":"iRhythm Technologies (IRTC) just used a major cardiac conference to show that its Zio ECG patch performs similarly for Asian and non Asian patients, a data driven win for its global expansion story.\nSee our latest analysis for iRhythm Technologies.\nThat backdrop helps explain why, even after a softer patch with a recent pullback in the 7 day share price return and some consolidation in the past month, iRhythm’s year to date share price return of over 100% and robust 1 year total shareholder...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice2-main-header/1585186837163","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice2-main-header/1585186837163"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-irtc/irhythm-technologies/news/irhythm-technologies-irtc-valuation-after-new-global-zio-ecg","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-irtc/irhythm-technologies/news/irhythm-technologies-irtc-valuation-after-new-global-zio-ecg","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4563","ECG","BK4082","BK4129","IRTC"],"gpt_icon":0},{"id":"2586788187","title":"Zio ECG Study Shows Cross-Population Efficacy and Might Change The Case For Investing In iRhythm Technologies (IRTC)","url":"https://stock-news.laohu8.com/highlight/detail?id=2586788187","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586788187?lang=en_us&edition=fundamental","pubTime":"2025-11-28 15:18","pubTimestamp":1764314328,"startTime":"0","endTime":"0","summary":"iRhythm Technologies recently announced results from a large U.S. study presented at APHRS 2025, showing their Zio long-term ECG monitoring service delivered consistent performance and diagnostic yield for both Asian and non-Asian patients over a 14-day monitoring period.\nThis cross-population evidence, bolstered by advanced AI analytics and broad clinical validation, is especially relevant for global markets where differences in patient demographics and lifestyle can affect device...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice2-main-header/1585186837163","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice2-main-header/1585186837163"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-irtc/irhythm-technologies/news/zio-ecg-study-shows-cross-population-efficacy-and-might-chan","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-irtc/irhythm-technologies/news/zio-ecg-study-shows-cross-population-efficacy-and-might-chan","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["ECG","BK4082","IRTC","BK4129","BK4563"],"gpt_icon":0},{"id":"2586243063","title":"Transtek Medical Electronics' Unit Renews Registration Certificate for ECG Information Network Software","url":"https://stock-news.laohu8.com/highlight/detail?id=2586243063","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586243063?lang=en_us&edition=fundamental","pubTime":"2025-11-27 17:10","pubTimestamp":1764234603,"startTime":"0","endTime":"0","summary":"Guangdong Transtek Medical Electronics'  unit, Shenzhen Ruikang Hongye Technology Development, renewed its medical device registration certificate for its ECG information network management system software, according to a Wednesday disclosure on the Shenzhen bourse.The Chinese medical device manufacturer's shares closed 2% higher on Thursday.The Guangdong Provincial Medical Products Administration approved the renewal.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4129","BK4134","300562","III","BK0251","BK0109","BK0114","ECG"],"gpt_icon":0},{"id":"2586264035","title":"NeuralCloud Expands AI ECG Technology into Equine Health with Equimetrics Partnership","url":"https://stock-news.laohu8.com/highlight/detail?id=2586264035","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586264035?lang=en_us&edition=fundamental","pubTime":"2025-11-27 02:38","pubTimestamp":1764182334,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Aiml Resources ( ($TSE:AIML) ). NeuralCloud Solutions Inc., a subsidiary of AI/ML Innovations Inc., has signed ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/neuralcloud-expands-ai-ecg-technology-into-equine-health-with-equimetrics-partnership?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/neuralcloud-expands-ai-ecg-technology-into-equine-health-with-equimetrics-partnership?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4551","BK4587","ECG","BK4023","BK4129","BK4585","AI","BK4588","BK4543","BK4528"],"gpt_icon":0},{"id":"2584996011","title":"Everus Construction Group (NYSE:ECG): Assessing Valuation After Recent Share Price Volatility","url":"https://stock-news.laohu8.com/highlight/detail?id=2584996011","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584996011?lang=en_us&edition=fundamental","pubTime":"2025-11-19 08:39","pubTimestamp":1763512786,"startTime":"0","endTime":"0","summary":"Everus Construction Group (NYSE:ECG) has seen some shifts in its stock price lately, catching the attention of investors tracking its recent moves. While not driven by headline news, the trends may offer clues about underlying sentiment.\nSee our latest analysis for Everus Construction Group.\nAfter a strong start to the year, Everus Construction Group’s share price has pulled back recently, shedding 14.5% over the past week but still holding onto a resilient 23.5% share price gain...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/3041000-choice1-main-header/1585186744280","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/3041000-choice1-main-header/1585186744280"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/capital-goods/nyse-ecg/everus-construction-group/news/everus-construction-group-nyseecg-assessing-valuation-after","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/capital-goods/nyse-ecg/everus-construction-group/news/everus-construction-group-nyseecg-assessing-valuation-after","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["NYSE","ECG","DCF","BK4129"],"gpt_icon":0},{"id":"2584626137","title":"Everus Construction Group Names Kenny Whipple Vice President of Business Development","url":"https://stock-news.laohu8.com/highlight/detail?id=2584626137","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584626137?lang=en_us&edition=fundamental","pubTime":"2025-11-17 21:30","pubTimestamp":1763386216,"startTime":"0","endTime":"0","summary":"Everus Construction Group Inc. has appointed Kenneth L. \"Kenny\" Whipple as vice president of business development. Whipple previously served as a senior project manager at Bombard Electric, an Everus operating company, and brings nearly 20 years of supervisory and project management experience to his new role.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Everus Construction Group Inc. published the original content used to generate this news brief via Business Wire  on November 17, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251117:nNDL1HQCm3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ECG","BK4129"],"gpt_icon":0},{"id":"2583656888","title":"Press Release: JD.com Announces Third Quarter 2025 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2583656888","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583656888?lang=en_us&edition=fundamental","pubTime":"2025-11-13 17:30","pubTimestamp":1763026200,"startTime":"0","endTime":"0","summary":"BEIJING, Nov. 13, 2025  -- JD.com, Inc. , a leading supply chain-based technology and service provider, today announced its unaudited financial results for the three months ended September 30, 2025.-- Net revenues were RMB299.1 billion  for the third. quarter of 2025, an increase of 14.9% from the third quarter of 2024.billion  for the third quarter of 2025, compared to. RMB11.7 billion for the third quarter of 2024. Non-GAAP2 net income.  for the third quarter of 2025, compared to RMB13.2. -- Diluted net income per ADS was RMB3.39  for the third quarter of. net income per ADS was RMB3.73  for the third quarter of 2025,billion) for the third quarter of 2025, compared to RMB11.6 billion for. \"In the third quarter, our total revenues increased by 14.9% year-on-year, driven by healthy momentum across our business lines,\" said Ian Su Shan, Chief Financial Officer of JD.com. \"JD Retail revenues were up 11.4% year-on-year in the quarter. In particular, growth of the general merchandise categ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"ff5052f934f04833a1c383f6b48c57d6","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ECG","BK4524","LU0048580855.USD","BK4531","BK4505","HK0000306685.HKD","LU0708995583.HKD","BK1619","LU0052750758.USD","LU1282651121.HKD","LU0348805143.USD","BK1575","BK4503","LU2257852520.SGD","BK4558","HK0000306701.USD","LU1282651048.USD","LU0149721374.USD","LU0039217434.USD","BK4220","LU0211977185.USD","BK4022","LU0543330483.HKD","LU0314109678.HKD","LU0359201612.USD","LU0345776255.USD","89618","LU0588545904.SGD","LU0315178854.USD","R","LU0320764599.SGD","LU0084288322.USD","SG9999002463.SGD","HK0000320264.USD","LU0791591158.USD","LU0499858602.USD","LU0315179316.USD","LU1023057109.AUD","LU2039709279.SGD","09618","BK4526","LU0456842615.SGD","BK4588","JD","LU0672654166.SGD","LU0359202008.SGD","LU0531971595.HKD","LU1794554557.SGD","LU1688375341.USD","LU0345775950.USD"],"gpt_icon":1},{"id":"2583301520","title":"HeartBeam (NASDAQ: BEAT) Recognized as a Top Global Innovator in Portable ECG Technology","url":"https://stock-news.laohu8.com/highlight/detail?id=2583301520","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583301520?lang=en_us&edition=fundamental","pubTime":"2025-11-13 02:00","pubTimestamp":1762970424,"startTime":"0","endTime":"0","summary":"Austin, Texas, United States, November 12th, 2025, FinanceWire The company was ranked second worldwide out of 243 companies evaluated in 12-lead EC...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/newswire/heartbeam-nasdaq-beat-recognized-as-a-top-global-innovator-in-portable-ecg-technology?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/newswire/heartbeam-nasdaq-beat-recognized-as-a-top-global-innovator-in-portable-ecg-technology?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MNQmain","TSYW.SI","ECG","QID","QLD",".IXIC","NQmain","BK4082","USJW.SI","BK4129","BEAT","NVIW.SI","USAW.SI","PSQ","TQQQ","SQQQ"],"gpt_icon":0},{"id":"2582390887","title":"AI/ML Innovations Secures U.S. Patent for ECG Signal-Processing Technology","url":"https://stock-news.laohu8.com/highlight/detail?id=2582390887","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582390887?lang=en_us&edition=fundamental","pubTime":"2025-11-12 05:07","pubTimestamp":1762895247,"startTime":"0","endTime":"0","summary":"The latest update is out from Aiml Resources ( ($TSE:AIML) ). AI/ML Innovations Inc. has announced the granting of a U.S. patent for its core ECG s...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/ai-ml-innovations-secures-u-s-patent-for-ecg-signal-processing-technology?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/ai-ml-innovations-secures-u-s-patent-for-ecg-signal-processing-technology?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4587","BK4528","ECG","BK4588","BK4023","BK4129","AI","BK4585","BK4543","BK4551"],"gpt_icon":0},{"id":"2582334882","title":"CardioComm Secures Funding for ECG Platform Expansion","url":"https://stock-news.laohu8.com/highlight/detail?id=2582334882","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582334882?lang=en_us&edition=fundamental","pubTime":"2025-11-11 13:02","pubTimestamp":1762837341,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Cardiocomm Solutions ( ($TSE:EKG) ). CardioComm Solutions has received approval from the TSX Venture Exchange f...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/cardiocomm-secures-funding-for-ecg-platform-expansion?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/cardiocomm-secures-funding-for-ecg-platform-expansion?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ECG","BK4129"],"gpt_icon":0},{"id":"2582870828","title":"Everus Construction Group Inc. details growth strategy and national platform in investor presentation","url":"https://stock-news.laohu8.com/highlight/detail?id=2582870828","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582870828?lang=en_us&edition=fundamental","pubTime":"2025-11-10 22:46","pubTimestamp":1762785981,"startTime":"0","endTime":"0","summary":"Everus Construction Group Inc. has released a new investor presentation highlighting its position as a leading national construction services provider with a network of 19 market-leading local brands and approximately 8,700 employees. The company reported total revenues of $3.49 billion and a backlog of $2.95 billion, with 43,000+ projects completed in 2024. Everus' operations are primarily focused on specialty contracting, including electrical and mechanical services, as well as transmission and distribution, with 76% of revenues from electrical and mechanical services and 24% from transmission and distribution. The company serves a diverse customer base across utility, commercial, institutional, industrial, and renewables markets. Everus is pursuing targeted commercial growth, operational excellence, and disciplined capital allocation, including investments in organic growth and strategic acquisitions. The company maintains an EBITDA of $223 million with an 8.3% EBITDA margin. You ca","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251110:nNDLb1LMn6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ECG","BK4129"],"gpt_icon":0},{"id":"2581839616","title":"MDU Resources Group Inc. highlights focus on regulated energy delivery and growth strategy in new investor presentation","url":"https://stock-news.laohu8.com/highlight/detail?id=2581839616","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581839616?lang=en_us&edition=fundamental","pubTime":"2025-11-08 04:49","pubTimestamp":1762548596,"startTime":"0","endTime":"0","summary":"MDU Resources Group Inc. has released a new investor presentation providing an overview of its current business strategy and financial highlights. The company now operates as a pure-play regulated energy delivery business, following successful spinoffs of Knife River and Everus Construction Group. MDU Resources serves over 1.2 million customers across eight states through its electric, natural gas distribution, and pipeline segments. As of September 30, 2025, the business mix includes significant contributions from electric, natural gas, and pipeline operations. The company reported a rate base with diversified holdings and continues to emphasize operational diversification and a supportive regulatory environment. You can access the full presentation through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251107:nNDL904HMp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ECG","BK4011","BK4129","BK4197","KNF","LU0566484027.USD","LU1559883803.SGD","MDU","BK4208"],"gpt_icon":0},{"id":"2581208095","title":"Everus Construction Group Inc : Oppenheimer Raises Target Price to $105 From $90","url":"https://stock-news.laohu8.com/highlight/detail?id=2581208095","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581208095?lang=en_us&edition=fundamental","pubTime":"2025-11-06 21:29","pubTimestamp":1762435776,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251106:nFWN3WI2DB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ECG","BK4129"],"gpt_icon":0},{"id":"2581779051","title":"Stifel Nicolaus Keeps Their Buy Rating on Everus Construction Group, Inc. (ECG)","url":"https://stock-news.laohu8.com/highlight/detail?id=2581779051","media":"TIPRANKS","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581779051?lang=en_us&edition=fundamental","pubTime":"2025-11-05 23:17","pubTimestamp":1762355825,"startTime":"0","endTime":"0","summary":"Stifel Nicolaus analyst Brian Brophy maintained a Buy rating on Everus Construction Group, Inc. today and set a price target of $94.00. Brophy cove...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/stifel-nicolaus-keeps-their-buy-rating-on-everus-construction-group-inc-ecg-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/stifel-nicolaus-keeps-their-buy-rating-on-everus-construction-group-inc-ecg-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ECG","SF"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":1,"totalSize":73,"code":"91000000","status":"200"}]}}